Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination

Obstetrics and Gynecology

Volumn 125, Issue 6, 2015, Pages 1433-1438

  Morgan, Jamie L ^a   Baggari, Sangameshwar R ^a   McIntire, Donald D ^a   Sheffield, Jeanne S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HYDROXYPROGESTERONE;

ADOLESCENT; ADULT; APGAR SCORE; ARTICLE; ASSISTED VENTILATION; BLOOD PH; BRAIN HEMORRHAGE; CHILD HOSPITALIZATION; CHORIOAMNIONITIS; COHORT ANALYSIS; DIPHTHERIA; FEMALE; GESTATIONAL AGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTIPARA; NEWBORN DEATH; NEWBORN SEPSIS; PERTUSSIS; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SMALL FOR DATE INFANT; STILLBIRTH; TETANUS; VACCINATION; PREGNANCY; PREMATURE BIRTH; THIRD TRIMESTER PREGNANCY; UNITED STATES; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; ADULT; DIPHTHERIA; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, SMALL FOR GESTATIONAL AGE; LENGTH OF STAY; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PREMATURE BIRTH; PRENATAL CARE; RETROSPECTIVE STUDIES; TETANUS; TEXAS; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 84929862438     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000862     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. Pertussis: outbreak trends. Available at: http://www.cdc.gov/pertussis/outbreaks/ trends.html. Retrieved November 21, 2014.
2. Clark TA, Messionnier NE, Hadler SC. Pertussis control: time for something new? Trends Microbiol 2014;20:211-3.
3. Winter K, Glaser C, Watt J, Harriman K; Centers for Disease Control and Prevention (CDC). Pertussis epidemic-California, 2014. MMWR Morb Mortal Wkly Rep 2014;63:1129-32.
4. Cherry JD. Epidemic pertussis in 2012-the resurgence of a vaccine-preventable disease. N Engl J Med 2012;367:785-7.
5. Centers for Disease Control and Prevention (CDC). Updated recommendations for the use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62:131-5.
6. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged ,12 months-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1424-6.
7. Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013;56:539-44.
8. Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Whales, 2012-2013. Clin Infect Dis 2015;60:333-7.
9. Van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J 2005;24 (suppl):S62-5.
10. Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KP. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine 2010;28:8001-7.
11. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011; 204:334.e1-5.
12. Zheteyava YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Fevzina NV, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012:207: 59.e1-7.
13. Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014;311:1760-9.
14. Abstracts of the 27th International Conference on Pharmacoe-pidemiology and Therapeutic Risk Management. Chicago, Illinois, USA. August 14-17, 2011. Pharmacoepidemiol Drug Saf 2011;20(suppl 1):S1-364.
15. Donegan K, King B, Brian P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014;349: g4219.
16. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway A, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA 2014;312:1897-904.
17. Housey M, Zhang F, Miller C, Lyon-Callo S, McFadden J, Garcia E, et al. Vaccination with tetanus, diphtheria, and acel-lular pertussis vaccine of pregnant women enrolled in Medicaid -Michigan, 2011-2013. MMWR Morb Mortal Wkly Rep 2014;63:839-42.
18. Goldfarb IT, Little S, Brown J, Riley LE. Use of the combined tetanus-diphtheria and pertussis vaccine during pregnancy. Am J Obstet Gynecol 2014;211:299.e1-5.
19. Partridge S, Balayla J, Holcroft CA, Abenhaim HA. Inadequate prenatal care utilization and risks of infant mortality and poor birth outcome: a retrospective analysis of 28,729,765 U.S. deliveries over 8 years. Am J Perinatol 2012;29:787-93.
20. Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among pregnant women-United States, 2012-2013 influenza season. MMWR Morb Mortal Wkly Rep 2013;62:787-92.
21. Shrank WH, Patrick AR, Brookhart MA. Healthy user and related biases in observational studies of preventative interventions: a primer for physicians. J Gen Intern Med 2010;26: 546-50.